1. Academic Validation
  2. Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection

Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection

  • Pharmacol Res. 2020 Jul;157:104837. doi: 10.1016/j.phrs.2020.104837.
Roberto Maggio 1 Giovanni U Corsini 2
Affiliations

Affiliations

  • 1 Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy. Electronic address: roberto.maggio@univaq.it.
  • 2 Former Professor of Pharmacology, School of Medicine, University of Pisa, Italy. Electronic address: gucorsini@tiscali.it.
Figures
Products